During the past decade, Buddhist Dalin Tzu Chi General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Buddhist Dalin Tzu Chi General Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Dalin Tzu Chi General Hospital" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "National Taiwan University Hospital" with 2 trials sponsored and "Buddhist Tzu Chi General Hospital" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buddhist Dalin Tzu Chi General Hospital" #1 collaborator was "National Science Council, Taiwan" with 2 trials as a collaborator, "Department of Health, Executive Yuan, R.O.C. (Taiwan)" with 1 trials as a collaborator, "Felix Leung, MD, Sepulveda Ambulatory Care Center, VAGLAHS" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Buddhist Dalin Tzu Chi General Hospital" are "Hepatitis C" (2 trials), "Psoriatic Arthritis" (2 trials), "Adenoma" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Buddhist Dalin Tzu Chi General Hospital" in a lesser frequency.

Most popular intervention types in "Buddhist Dalin Tzu Chi General Hospital" are "Drug" (11 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tofacitinib" (2 trials), "placebo" (2 trials), "Adalimumab" (1 trials) and "Air insufflation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Buddhist Dalin Tzu Chi General Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Buddhist Dalin Tzu Chi General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Buddhist Dalin Tzu Chi General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Buddhist Dalin Tzu Chi General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".